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A B S T R A C T
AIM: The purpose of this study was to evaluate the safety and effectiveness of the 
multilayer flow modulator and its delivery system for totally endovascular repair of 
aortic aneurysms in high risk patients and to demonstrate deployment success and 
preservation of all side-branch vessels.
METHODS AND RESULTS: We report on 22 cases (mean age 67 ± 5 years all males) 
with thoracic, thoracoabdominal and abdominal aneurysm considered high risk pa-
tients for surgical treatment. In all patients, treated with a multilayer stent, there were 
side branches arising from the aneurysm sac and maintained patency after the pro-
cedure. Two patients died after the procedure: 1 patient who developed a stroke two 
weeks post procedure and 1 patient who sustained a myocardial infarction two days 
post-procedurally. No vascular or systematic complications were observed in the other 
20 patients in the short and long term follow-up. 
CONCLUSIONS: Our preliminary results indicate that the use of the multilayer stent 
is feasible and seems to be safe for the management of aortic aneurysm with side 
branches.
I N T R O D U C T I O N
Aortic aneurysms represent the 13th leading cause of death in the U.S. Aortic an-
eurysm is a significant disease that usually leads to death from rupture if not treated in 
time. Each year, about 15,000 people in the United States die of a ruptured aneurysm. 
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Fortunately, not all aneurysms rupture right away. Many grow 
very slowly and cause no symptoms.
Most aneurysms occur in people aged 55 years or older 
and are 4 times more common in men than in women. Aortic 
aneurysm is most common in the abdominal aorta (AAA) 
than in the thoracic aorta (TAA). The management of aortic 
aneurysm may be medical, surgical or endovascular. In our 
laboratory we follow the endovascular treatment whenever it 
is indicated. Furthermore, many cases, especially when col-
laterals are arising throughout the aneurysm are not suitable 
for endovascular treatment by use of the classical covered 
endografts and a new method of treatment with a multilayer 
stent is used.
Aneurysms are classified into several different types. Ac-
cording to aneurysm position, we have thoracic aneurysms of 
the ascending aorta, the aortic arch, or the descending aorta; 
abdominal aneurysms of suprarenal, juxtarenal, or infrarenal 
location, and; thoracoabdominal aneurysms. According to 
their morphology, we have fusiform and saccular aneurysms. 
According to their formation, we have true aneurysms and 
false or pseudo aneurysms. According to their pathogenesis, 
aneurysms are classified into degenerative/atherosclerotic, 
traumatic, dissecting, infective (bacterial / syphilitic), connec-
tive tissue disorders (Marfan / Ehlers – Danlos syndromes), 
arteritis (Takayasu), congenital, drug-induced (cocaine / 
amphetamines, etc).
Three recently published reports have demonstrated that 
the application of the multilayer stent results in effective 
treatment of aortic dissection, thoracoabdominal and renal 
aneurysm.1-3 Our study was conducted to prove the feasibility 
of using the multilayer stent in order to treat a patient with high 
surgical risk, who has an aortic aneurysm with side branches. 
M E T H O D S 
A study protocol was designed to examine the safety and 
efficacy of the Cardiatis Multilayer Stent in high risk patients 
with aortic aneurysms. Between December 2006 and Decem-
ber 2011, 22 male patients were enrolled in the study: 1 patient 
with thoracic aneurysm (diameter, 57 mm), 3 abdominal (mean 
diameter 76 mm) and 18 thoracoabdominal (mean diameter 
58 mm).
S T U D Y  P R O C E D U R E
Prior to the endovascular treatment with the multilayer 
stent, patients underwent baseline evaluation that included 
physical examination, review of medications and full screening 
of biochemical profile. A pre-procedural thoracic, abdominal 
or thoracoabdominal computed tomography (CT) angiogram 
was performed in each patient. 
The device was inserted via the right or left femoral artery 
and was placed at the aneurysm.
R E S U L T S 
The multilayer stent was successfully deployed in all 
patients (100% technical success). Mean follow-up for the 
thoracic aneurysm was 28 months, for the aortic aneurysms 
was 12 months and for thoracoabdominal aneurysm 12 months. 
The one- month follow up CT angiogram for the thoracic, the 
abdominal and thoracoabdominal aneurysms, showed patent 
arterial side branches and reduced blood flow inside the sac. 
The 6 and 12 month follow up CT angiogram showed patent 
arterial side branches, thrombus inside the sac or shrinkage 
of the sac. 
D I S C U S S I O N
The multilayer self-expandable stent consists of a 3D 
braided tube; it is built as a structure involving several inter-
connected layers, as shown in Figure 1. 
The number of layers is adaptable to the application site, 
femoral or carotid stenosis, cerebral or aortic aneurysm It has 
a high kinking resistance and high resistance to fatigue due to 
the interlocked layers (Fig. 2).
When the aneurysm is sacular without branch, we have an 
organized stable thrombus. It will resorb with time.
The particle image velocimetry (PIV) method was used 
to show that we can follow the movement of 1 vortex with 
FIGURE 1. 3D structure.
FIGURE 2. High kinking resistance.
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time at a rate of 25 images/s. We can see that more the vortex 
moves along the aneurismal wall more it becomes stronger 
(like a hurricane with an eye). This vortex will be followed be 
another one, etc (Fig. 4).
Figure 5 shows, at equal time, that the stent slows down 
the movement speed of the vortex and reduces its force. The 
speed reduction creates a kind of “traffic jam” like in the high 
way which leads to thrombosis.
In Figure 6, the image on the left shows that the vortexes 
do not follow the same way when they enter in the aneurys-
mal sac, however in the image on the right the vortexes are 
aligned, they follow the same trajectory, that’s why it leads 
to thrombosis. Now this behavior is effective when the stent 
has enough density of the mesh as the multilayer (this is not 
possible with the monolayer stent).
When the aneurysm has a branch, there is no thrombus 
formation. The whole flow entering the aneurysm is aspirated 
by the branch and no flow stagnates along the aneurysmal wall; 
what is happening is that the wall falls down which leads to 
its shrinkage. This unique behavior keeps the branch patent.
All the flow is directed to the branch. The more the flow is 
moving toward the branch the more it creates a barrier between 
the aneurysmal wall of the branch. This is directed by the lay-
ers, this is not possible by a normal stent. If we add the 2 types 
of the aneurysm discussed above we get an abdominal aortic 
aneurysm. When the sac of the aneurysm is stretched the flow 
is laminated and the area where we have the mesenteric or 
other arteries is shrunk. It should be noted that the large stents 
for the aortic applications can be inserted percutaneously.
C O N C L U S I O N 
The Cardiatis Multilayer Stent seems to be efficacious as 
the side branches remain patent and the aneurysm is excluded. 
The question remains about the time needed to reach the 
optimum result after stenting the aneurysm in large arteries 
such as the thoracic and abdominal aorta. We believe this phe-
nomenon is related to the number and size of the side branches 
within the aneurysm. A larger multi center study is underway 
to confirm the suitability of Cardiatis Multilayer Stent for the 
large thoracic, abdominal and thoracoabdominal aneurysms.
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